
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>CASSIA Hypothesis Generation Report</title>
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: #333;
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
            background-color: #f9f9f9;
        }
        h1, h2 {
            color: #2c3e50;
            border-bottom: 2px solid #3498db;
            padding-bottom: 10px;
        }
        .report-header {
            text-align: center;
            margin-bottom: 40px;
        }
        .report-header p {
            font-size: 1.1em;
            color: #555;
        }
        .cluster-section {
            background-color: #ffffff;
            border: 1px solid #e1e1e1;
            border-radius: 8px;
            padding: 25px;
            margin-bottom: 30px;
            box-shadow: 0 4px 6px rgba(0,0,0,0.05);
        }
        table {
            width: 100%;
            border-collapse: collapse;
            margin-top: 20px;
        }
        th, td {
            padding: 12px 15px;
            text-align: left;
            border-bottom: 1px solid #ddd;
        }
        th {
            background-color: #3498db;
            color: white;
        }
        tr:nth-child(even) {
            background-color: #f2f2f2;
        }
        tr:hover {
            background-color: #eaf5ff;
        }
        details {
            margin-top: 20px;
            border: 1px solid #ddd;
            border-radius: 4px;
            padding: 10px;
        }
        summary {
            font-weight: bold;
            cursor: pointer;
            color: #3498db;
        }
        pre {
            background-color: #2c3e50;
            color: #f8f8f2;
            padding: 15px;
            border-radius: 4px;
            white-space: pre-wrap;
            word-wrap: break-word;
            font-family: "Courier New", Courier, monospace;
        }
        .footer {
            text-align: center;
            margin-top: 40px;
            font-size: 0.9em;
            color: #777;
        }
    </style>
</head>
<body>
    <div class="report-header">
        <h1>CASSIA Hypothesis Generation Report</h1>
        <p>Generated on: 2025-07-07 17:12:48</p>
        <p>Source file: 20250707-171226_run2_human_bone_marrow_openai_gpt-4o-2024-11-20.json</p>
    </div>

    
<div class="cluster-section">
    <h2>Cluster: CD14 Mono</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Classical Monocytes (CD14+ Monocytes)</td>
                    <td>Characterized by high expression of CD14 and other key supporting marker genes like S100A8, S100A9, S100A12, VCAN, and FCN1, indicating their role in inflammation and innate immunity.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Non-Classical Monocytes (CD16+ Monocytes)</td>
                    <td>Supported by marker genes such as TREM1, LRRK2, CCR1, and CLEC4E, suggesting a patrolling function in blood vessels and involvement in tissue repair.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Macrophages (Tissue-Resident or Differentiated Monocyte-Derived Macrophages)</td>
                    <td>Indicated by the presence of hallmark markers like CD163, along with VCAN and other markers associated with phagocytosis and tissue remodeling, suggesting differentiated monocytes in tissues.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided marker genes, this cluster is most likely associated with **monocytes/macrophages** or related myeloid cell types, given the strong expression of genes typically associated with monocyte/macrophage identity and function. Here's a breakdown of the top 3 most likely subtypes:

---

### 1. **Classical Monocytes (CD14+ Monocytes)**
   - **Key supporting marker genes:** CD14, S100A8, S100A9, S100A12, VCAN, FCN1, TLR2, TLR4, CLEC7A, CSF3R, FCGR2A, CD163.
   - Classical monocytes are the most abundant subset of monocytes in circulation and are characterized by high expression of CD14 and low/absent CD16 (not mentioned in this list). They play a role in inflammation and innate immunity.

---

### 2. **Non-Classical Monocytes (CD16+ Monocytes)**
   - **Key supporting marker genes:** TREM1, LRRK2, CCR1, CLEC4E, FPR1, CD300E, TNFAIP2, SERPINA1.
   - Non-classical monocytes patrol blood vessels and are involved in tissue repair and homeostasis. While this list includes some markers shared with classical monocytes, markers like TREM1 and LRRK2 suggest a possible non-classical or intermediate monocyte identity.

---

### 3. **Macrophages (Tissue-Resident or Differentiated Monocyte-Derived Macrophages)**
   - **Key supporting marker genes:** CD163, MERTK (implied by downstream pathways of CD163), VCAN, FGL2, PLAUR, LRP1, CD93, SLC11A1.
   - Macrophages are differentiated monocytes that have entered tissues. The presence of CD163 (a hallmark of macrophages), along with VCAN and other markers involved in phagocytosis and tissue remodeling, suggests this cluster may also include macrophages.

---

### Additional Notes:
- The presence of inflammatory markers such as S100A8, S100A9, S100A12, and TREM1 suggests an **inflammatory or activated state** of these myeloid cells.
- If this cluster was derived from a disease context (e.g., bone marrow from a patient with inflammation, infection, or cancer), the profile could represent **activated monocytes/macrophages** involved in immune responses.

### Summary:
The top 3 most likely subtypes are:
1. Classical monocytes.
2. Non-classical monocytes.
3. Macrophages (tissue-resident or monocyte-derived).</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: CD16 Mono</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Non-classical Monocytes (CD16+ Monocytes)</td>
                    <td>A hallmark marker of non-classical monocytes, FCGR3A (CD16), is present, along with other commonly expressed monocyte genes like C1QA, MS4A7, MAFB, LST1, CXCL16, SIGLEC10, LILRB1, and LILRB2.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Macrophages (Tissue-Resident or Inflammatory)</td>
                    <td>Canonical markers of macrophages, CSF1R, ADGRE1 (F4/80), and MAFB, are present, indicating differentiation into macrophages from monocytes, along with genes associated with macrophage activation and inflammatory responses.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Intermediate Monocytes (CD14+CD16+)</td>
                    <td>Genes expressed in intermediate monocytes, such as CDKN1C, FCGR3A (CD16), C1QA, and MAFB, are present, which share features of both classical and non-classical monocytes.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided marker genes, the cell cluster in question is most likely a subtype of **monocytes/macrophages** or related myeloid lineage cells. Below are the top 3 most likely detailed subtypes that this cluster could represent, along with reasoning:

---

### **1. Non-classical Monocytes (CD16+ Monocytes)**  
- **Key Marker Genes Supporting This:**  
  - **FCGR3A (CD16):** A hallmark marker of non-classical monocytes.  
  - **C1QA, MS4A7, MAFB, LST1, CXCL16:** These are commonly expressed in monocytes, particularly non-classical subsets.  
  - **SIGLEC10, LILRB1, LILRB2:** These genes are also associated with monocyte immune regulation and are expressed in non-classical monocytes.  

- **Description:**  
  Non-classical monocytes are a subset of monocytes involved in patrolling endothelial surfaces and resolving inflammation. They are characterized by high expression of CD16 (FCGR3A) and low expression of CD14.

---

### **2. Macrophages (Tissue-Resident or Inflammatory)**  
- **Key Marker Genes Supporting This:**  
  - **CSF1R, ADGRE1 (F4/80), MAFB:** These are canonical markers of macrophages, indicating differentiation into macrophages from monocytes.  
  - **HMOX1, C5AR2, SIGLEC10:** These are associated with macrophage activation and inflammatory responses.  
  - **C1QA, MS4A4A, MS4A7, LST1:** These are often expressed in macrophages, particularly tissue-resident or inflammatory subtypes.  

- **Description:**  
  Macrophages are differentiated monocytes found in tissues, where they perform phagocytosis, immune surveillance, and inflammatory responses. The presence of markers like CSF1R and ADGRE1 suggests a macrophage identity.

---

### **3. Intermediate Monocytes (CD14+CD16+)**  
- **Key Marker Genes Supporting This:**  
  - **CDKN1C, FCGR3A (CD16), C1QA, MAFB:** These are expressed in intermediate monocytes, which share features of both classical and non-classical monocytes.  
  - **HMOX1, CSF1R, LILRB1, LILRB2:** These genes are involved in monocyte activation and immune regulation, consistent with intermediate monocytes.  

- **Description:**  
  Intermediate monocytes are a transitional subset between classical and non-classical monocytes. They play roles in antigen presentation and inflammatory signaling.

---

### **Additional Notes:**
- The presence of genes like **BATF3, TCF7L2, and NR4A1** suggests immune regulatory functions, which are consistent with monocytes/macrophages.
- Some genes, such as **CEACAM3 and ICAM4**, may indicate specific functional adaptations or activation states, such as phagocytosis or adhesion.

---

### **Summary of Top 3 Likely Subtypes:**
1. **Non-classical Monocytes (CD16+ Monocytes)**  
2. **Macrophages (Tissue-Resident or Inflammatory)**  
3. **Intermediate Monocytes (CD14+CD16+)**

These subtypes are all part of the myeloid lineage and are commonly found in human bone marrow, where monocyte precursors differentiate and mature.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: CD4 Memory</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Effector/Memory CD4+ T Cells (T Helper Cells)</td>
                    <td>The presence of markers like GATA3, IL7R, CD40LG, PRDM1, TNFRSF4 (OX40), RORA, and IL32 strongly suggests this cluster represents CD4+ effector/memory T cells, likely including Th2, Th17, or other activated helper T cell subsets.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Effector/Memory CD8+ T Cells</td>
                    <td>This cluster could include CD8+ effector/memory T cells, indicated by markers such as CD2, TRAC, TRBC1, KLRB1 (CD161), TNFRSF25 (DR3), GPR183 (EBI2), and PIM2, which are involved in cytotoxic responses.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Regulatory T Cells (Tregs)</td>
                    <td>A subset of these cells might represent regulatory T cells, supported by markers like GATA3, TNFRSF4 (OX40), TNFRSF25 (DR3), IL7R, MAF, and ITGB1, which are critical for maintaining immune tolerance.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided list of marker genes, the cell cluster most likely represents a **T cell population**. Many of the markers listed are strongly associated with T cells and their subtypes, particularly memory T cells and helper T cells. Below are the top 3 most likely detailed subtypes for this cluster, based on the marker genes provided:

---

### **1. Effector/Memory CD4+ T Cells (T Helper Cells)**
   - **Key markers**: 
     - **GATA3**: A transcription factor crucial for T helper cell differentiation, especially Th2 cells.
     - **IL7R**: Expressed on T cells, particularly memory and naïve T cells.
     - **CD40LG**: Expressed on activated CD4+ T cells, important for T-B cell interactions.
     - **PRDM1**: Associated with effector and memory T cell differentiation.
     - **TNFRSF4 (OX40)**: A marker of activated T cells, including memory and effector CD4+ T cells.
     - **RORA**: Implicated in the development of Th17 cells and other T helper subsets.
     - **IL32**: Associated with cytokine production in activated T cells.

   - **Interpretation**: The presence of these markers strongly suggests that this cluster represents **CD4+ effector/memory T cells**, likely including Th2, Th17, or other activated helper T cell subsets.

---

### **2. Effector/Memory CD8+ T Cells**
   - **Key markers**:
     - **CD2**: Expressed on T cells, including CD8+ subsets.
     - **TRAC and TRBC1**: Components of the T cell receptor (TCR), indicating T cell identity.
     - **KLRB1 (CD161)**: Expressed on subsets of CD8+ T cells, particularly memory and effector cells.
     - **TNFRSF25 (DR3)**: A receptor expressed on activated T cells, including CD8+ T cells.
     - **GPR183 (EBI2)**: Involved in chemotaxis of activated T cells.
     - **PIM2**: Associated with T cell activation and survival.

   - **Interpretation**: This cluster could also include **CD8+ effector/memory T cells**, which are involved in cytotoxic responses and are often found in bone marrow during immune surveillance or after activation.

---

### **3. Regulatory T Cells (Tregs)**
   - **Key markers**:
     - **GATA3**: Also expressed in a subset of regulatory T cells (Tregs).
     - **TNFRSF4 (OX40)** and **TNFRSF25 (DR3)**: Both are expressed on activated Tregs.
     - **IL7R**: Found on some Tregs, particularly memory-like Tregs.
     - **MAF**: A transcription factor associated with Tregs and IL-10 production.
     - **ITGB1**: Linked to T cell adhesion and migration, including Tregs.

   - **Interpretation**: A subset of these cells might represent **regulatory T cells**, which are critical for maintaining immune tolerance and are often found in tissues like bone marrow.

---

### **Summary**
The top 3 most likely subtypes for this cell cluster are:
1. **Effector/Memory CD4+ T Cells (T Helper Cells)**
2. **Effector/Memory CD8+ T Cells**
3. **Regulatory T Cells (Tregs)**

The presence of T cell receptor components (e.g., TRAC, TRBC1), activation markers (e.g., TNFRSF4, TNFRSF25, CD40LG), and differentiation-related transcription factors (e.g., GATA3, PRDM1, MAF) strongly supports the identification of this cluster as T cells, likely a mix of activated and memory subtypes.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: CD4 Naive</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Naïve T cells (CD4+ or CD8+)</td>
                    <td>Marker genes like CCR7, LEF1, TCF7, and CD3D/CD3E/CD3G are highly characteristic, with CCR7 and LEF1 known for maintaining the naïve phenotype and homing.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Central memory T cells</td>
                    <td>The presence of CCR7, CD27, and LEF1 is consistent, as they retain homing ability and express markers overlapping with naïve T cells; SATB1 is also associated.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Regulatory T cells (Tregs)</td>
                    <td>While FOXP3 is not listed, the presence of CD27, IL6ST, and LEF1 could suggest a subset of regulatory T cells, particularly in the bone marrow.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided marker genes, this cell cluster is highly likely to represent **T cells** from human bone marrow, given the strong expression of multiple T cell-specific markers. Examining the specific markers in detail, we can identify the following most likely subtypes:

### Top 3 Most Likely Subtypes:
1. **Naïve T cells (CD4+ or CD8+):**
   - Marker genes like **CCR7**, **LEF1**, **TCF7**, and **CD3D/CD3E/CD3G** are highly characteristic of naïve T cells.
   - **CCR7** and **LEF1** are particularly known for their role in maintaining the naïve T cell phenotype and homing to lymphoid tissues.
   - **TRAC**, **TRBC1**, and **TRBC2** indicate the presence of T cell receptor (TCR) components, confirming the T cell identity.

2. **Central memory T cells:**
   - The presence of **CCR7**, **CD27**, and **LEF1** is also consistent with central memory T cells, which retain the ability to home to lymphoid tissues and express markers overlapping with naïve T cells.
   - **SATB1**, a chromatin regulator, is associated with T cell development and memory T cell differentiation.

3. **Regulatory T cells (Tregs):**
   - While specific Treg markers like **FOXP3** are not listed, the presence of **CD27**, **IL6ST**, and **LEF1** could suggest a subset of regulatory T cells, particularly in the bone marrow where Tregs may reside to regulate immune responses.

### Additional Notes:
- The strong expression of **CD3D**, **CD3E**, **CD3G**, and TCR-related genes (**TRAC**, **TRBC1**, **TRBC2**) confirms the T cell lineage.
- The presence of **CD40LG** and **TXK** further supports T cell activation potential or helper T cell subsets.
- **FLT3LG** is typically associated with dendritic cells but can also be expressed by T cells in certain contexts, especially in the bone marrow.

### Conclusion:
The cluster is most likely composed of **T cells**, with the top subtypes being:
1. Naïve T cells.
2. Central memory T cells.
3. Regulatory T cells.

Further validation could be performed using additional markers like **FOXP3** (for Tregs) or CD4/CD8 expression to distinguish helper vs. cytotoxic T cells.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: CD56 bright NK</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>CD56dim Cytotoxic NK Cells</td>
                    <td>Key markers like GNLY, GZMK, NKG7, KLRD1, KLRF1, and KIR genes (e.g., KIR2DL4) are present, indicating cytotoxic effector NK cells responsible for killing virally infected or tumor cells.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>CD56bright Regulatory NK Cells</td>
                    <td>Key markers include IL2RB, IL18R1, IL18RAP, AREG, and ID2, suggesting less cytotoxic but potent cytokine producers involved in immune regulation and tissue homeostasis.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>ILC1-like NK Cells</td>
                    <td>Key markers like ID2, TNFRSF18, TNFRSF4, GATA3, and BHLHE40 are present, indicating innate lymphoid cells with functional similarities to NK cells, involved in early immune responses.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided list of marker genes, this cell cluster is most likely a subtype of **natural killer (NK) cells** or **innate lymphoid cells (ILCs)**. These immune cells are known for their cytotoxic function and cytokine production, and the expression of genes like **KIR2DL4, KLRC1, KLRC2, GNLY, GZMK, NKG7, KLRD1, and KLRB1** strongly suggests an NK cell lineage. Below are the top three most likely subtypes:

### 1. **CD56dim Cytotoxic NK Cells**
   - **Key markers:** GNLY, GZMK, NKG7, KLRD1, KLRF1, and KIR genes (e.g., KIR2DL4).
   - These are the cytotoxic effector NK cells responsible for killing virally infected or tumor cells. They are commonly found in peripheral blood but also reside in bone marrow.

### 2. **CD56bright Regulatory NK Cells**
   - **Key markers:** IL2RB, IL18R1, IL18RAP, AREG, and ID2.
   - These are less cytotoxic but are potent cytokine producers, playing a role in immune regulation and tissue homeostasis. They are more prevalent in lymphoid tissues and bone marrow.

### 3. **ILC1-like NK Cells**
   - **Key markers:** ID2, TNFRSF18, TNFRSF4, GATA3, and BHLHE40.
   - ILC1s are innate lymphoid cells that share functional similarities with NK cells but are more tissue-resident and involved in early immune responses, particularly against intracellular pathogens.

### Supporting Evidence:
- **Cytotoxicity-related genes:** GNLY (granulysin), GZMK (granzyme K), and NKG7 are hallmark genes of cytotoxic NK cells.
- **Activation markers:** IL2RB, IL18R1, and TNFRSF18 are involved in NK cell activation and cytokine signaling.
- **KIR genes:** KIR2DL4 and other killer immunoglobulin-like receptors (KIRs) are specific to NK cells and mediate their recognition of target cells.
- **ILC-specific transcription factors:** ID2 and GATA3 are critical for the development and function of both NK cells and ILC1 subsets.

### Conclusion:
This cluster is most likely composed of NK cells, with a mix of **cytotoxic CD56dim NK cells**, **regulatory CD56bright NK cells**, and potentially **ILC1-like cells**. Further validation could involve assessing protein expression via flow cytometry (e.g., CD56, CD16, and KIR proteins) or functional assays.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: CD8 Effector_1</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>CD8+ Cytotoxic T Cells (Effector/Memory Subtype)</td>
                    <td>These are CD8+ T cells with cytotoxic activity, evidenced by CD8A/B, granzymes, perforin, and TBX21, with CCL5 and KLRG1 suggesting an effector/memory phenotype.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Natural Killer (NK) Cells (Cytotoxic Subtype)</td>
                    <td>NK cells express characteristic markers like KLRC2, KLRD1, KLRG1, and EOMES, along with cytotoxic mediators GZMH, PRF1, FGFBP2, and SH2D1A.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Innate-like T Cells (e.g., γδ T Cells or MAIT Cells)</td>
                    <td>The presence of TRGC2 and TRG-AS1 suggests a γδ T cell lineage, which are innate-like T cells that can express cytotoxic markers like granzymes and perforin.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the marker genes provided, the cell cluster most likely represents a subset of **cytotoxic lymphocytes**, specifically **natural killer (NK) cells** or **cytotoxic T cells**. These marker genes are characteristic of immune cells involved in cytotoxic activity, and their expression patterns can help further refine the subtype classification. Below are the top three most likely detailed subtypes:

### 1. **CD8+ Cytotoxic T Cells (Effector/Memory Subtype)**
   - **Key Marker Genes:** CD8A, CD8B, GZMH, GZMK, GZMA, PRF1, NKG7, TBX21 (T-bet), CCL5, KLRG1, TIGIT
   - **Rationale:** These cells are CD8+ T cells with cytotoxic activity, as evidenced by markers like CD8A and CD8B and the presence of granzyme (GZMH, GZMK, GZMA) and perforin (PRF1). TBX21 (T-bet) is a transcription factor associated with effector T cells. The presence of CCL5 and KLRG1 suggests a more differentiated effector or memory phenotype.

### 2. **Natural Killer (NK) Cells (Cytotoxic Subtype)**
   - **Key Marker Genes:** KLRC2 (NKG2C), KLRD1 (CD94), KLRG1, NKG7, GZMH, PRF1, FGFBP2, CCL4, CCL3L3, EOMES, SH2D1A
   - **Rationale:** NK cells are cytotoxic lymphocytes that express markers like KLRC2, KLRD1, and KLRG1, which are characteristic of NK cell receptors. EOMES is a transcription factor associated with NK cell development. The presence of cytotoxic mediators like GZMH, PRF1, and FGFBP2 further supports this subtype. Additionally, SH2D1A (SAP) is involved in signaling pathways critical for NK cell activity.

### 3. **Innate-like T Cells (e.g., γδ T Cells or MAIT Cells)**
   - **Key Marker Genes:** TRGC2, TRG-AS1, XCL2, CCL4, CCL3L3, GZMH, GZMA, PRF1, TBX21
   - **Rationale:** The presence of TRGC2 and TRG-AS1 suggests a γδ T cell lineage, which is a subset of T cells with innate-like functions. These cells can also express cytotoxic markers like granzymes (GZMH, GZMA) and perforin (PRF1). XCL2 and TBX21 are associated with innate-like T cell activity. Additionally, γδ T cells are commonly found in tissues and can exhibit cytotoxic functions.

---

### Summary of Likely Subtypes:
1. **CD8+ Cytotoxic T Cells (Effector/Memory)**
2. **Cytotoxic NK Cells**
3. **Innate-like T Cells (e.g., γδ T Cells)**

Further analysis, such as clustering based on gene expression levels, protein markers (flow cytometry or CyTOF), or TCR sequencing, would help confirm the exact subtype.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: CD8 Effector_2</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Cytotoxic CD8+ T cells (Effector or Effector Memory T cells)</td>
                    <td>Key markers like CD8A, GZMK, GZMA, CCL5, KLRG1, EOMES, and PRDM1 are associated with cytotoxic activity and effector functions of CD8+ T cells, particularly in an activated or memory state.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Natural Killer (NK) cells</td>
                    <td>While sharing many cytotoxic markers with CD8+ T cells, the presence of hallmark NK cell markers like KLRD1 (CD94) and KLRC2 (NKG2C) strongly suggests an NK cell population.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Mucosal-associated invariant T (MAIT) cells</td>
                    <td>MAIT cells are an innate-like T cell subset expressing cytotoxic markers and chemokines like CCL3/CCL4, with markers such as GZMK, GZMA, CCL3, CCL4, KLRD1, IL2RB, CD69, and CXCR4 being relevant.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided marker genes, this cell cluster is most likely a subset of **T cells** or **natural killer (NK) cells**, as many of the listed markers are characteristic of cytotoxic lymphocytes. Below are the top 3 most likely detailed subtypes:

---

### 1. **Cytotoxic CD8+ T cells (Effector or Effector Memory T cells)**
   - **Reasoning**:
     - Key markers: **CD8A**, **GZMK**, **GZMA**, **CCL5**, **KLRG1**, **EOMES**, **PRDM1**, **TIGIT**, and **IL2RB**.
     - These markers are associated with cytotoxic activity and effector functions of CD8+ T cells, particularly those in an activated or memory state.
     - **EOMES** and **PRDM1** (BLIMP1) are transcription factors involved in effector differentiation.
     - **KLRG1** is a marker of terminally differentiated effector T cells.
     - **CCL5** (RANTES) and **GZMA/GZMK** are critical for cytotoxic and chemotactic functions.

---

### 2. **Natural Killer (NK) cells**
   - **Reasoning**:
     - Key markers: **KLRD1 (CD94)**, **KLRC2 (NKG2C)**, **CD160**, **CCL3**, **CCL4**, **CCL5**, **XCL1**, and **GZMK**.
     - NK cells share many cytotoxic markers with CD8+ T cells, including **granzyme** and **chemokine production**.
     - The presence of **KLRD1** and **KLRC2** strongly suggests an NK cell population, as these are hallmark markers of NK cells.
     - **XCL1/XCL2** are chemokines specifically expressed by NK cells and cytotoxic T cells.
     - **CD160** is also commonly expressed on NK cells.

---

### 3. **Mucosal-associated invariant T (MAIT) cells**
   - **Reasoning**:
     - Key markers: **GZMK**, **GZMA**, **CCL3**, **CCL4**, **KLRD1**, **IL2RB**, **CD69**, and **CXCR4**.
     - MAIT cells are a subset of innate-like T cells that express cytotoxic markers and produce chemokines like **CCL3/CCL4** upon activation.
     - **CD69** is a marker of tissue residency, which is consistent with MAIT cells being enriched in certain tissues, including bone marrow.
     - **CXCR4** is involved in homing to the bone marrow, which is relevant for MAIT cells.

---

### Additional Notes:
- While the markers suggest cytotoxic lymphocytes, the exact subtype depends on the broader context of your data (e.g., clustering, co-expression patterns, and tissue microenvironment).
- The distinction between CD8+ T cells and NK cells can sometimes blur, as they share many functional characteristics. Further validation (e.g., protein-level markers like CD3 for T cells or CD56 for NK cells) may be needed.

</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: CD8 Memory_1</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>CD8+ Effector Memory T Cells (TEM)</td>
                    <td>Exhibit cytotoxic activity, involved in rapid immune responses, with markers like GZMK, GZMA for cytotoxic granule activity, CXCR3 and CCL5 for migratory capacity, and PRDM1 for terminal effector differentiation.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>CD8+ Cytotoxic T Cells (CTLs)</td>
                    <td>Primary cytotoxic effectors, capable of killing infected/cancerous cells, characterized by GZMA, GZMK, PRDM1, and TIGIT, with RUNX3 critical for differentiation.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>CD8+ Tissue-Resident Memory T Cells (TRM)</td>
                    <td>Specialized memory T cells residing in tissues, not recirculating, indicated by RORA, IL7R, ITK for tissue-resident phenotype, CD27 for memory, and CXCR3/CCL5 for tissue homing/retention.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided marker genes, the cell cluster is highly likely to represent a subset of T cells, specifically cytotoxic T cells. The presence of key genes such as **CD8A**, **CD8B**, **GZMK**, **PRDM1**, **TRAC**, **TRBC1**, and **GZMA** strongly suggests this. Additionally, the expression of genes like **CCL5**, **CXCR3**, **TIGIT**, **IL32**, **RUNX3**, and **STAT4** further supports the identification of T-cell subsets with cytotoxic and effector functions. Below are the top three most likely subtypes:

### 1. **CD8+ Effector Memory T Cells (TEM)**
   - **Key markers**: **CD8A**, **CD8B**, **GZMK**, **PRDM1**, **CCL5**, **CXCR3**, **IL32**, **TIGIT**, **RUNX3**
   - These cells exhibit cytotoxic activity and are involved in rapid immune responses. The expression of **GZMK** and **GZMA** indicates cytotoxic granule activity, while **CXCR3** and **CCL5** suggest a chemokine-mediated migratory capacity. **PRDM1** (Blimp-1) is a marker of terminal effector differentiation.

### 2. **CD8+ Cytotoxic T Cells (CTLs)**
   - **Key markers**: **CD8A**, **CD8B**, **GZMA**, **CCL5**, **CXCR3**, **IL32**, **CD96**, **TIGIT**
   - These cells are the primary cytotoxic effectors in the immune system, capable of killing infected or cancerous cells. The expression of **GZMA**, **GZMK**, **PRDM1**, and **TIGIT** is characteristic of activated or cytotoxic CD8+ T cells. **RUNX3** is a transcription factor critical for CD8+ T-cell differentiation.

### 3. **CD8+ Tissue-Resident Memory T Cells (TRM)**
   - **Key markers**: **CD8A**, **CD8B**, **ITK**, **RORA**, **CCL5**, **CXCR3**, **IL7R**, **CD27**
   - Tissue-resident memory T cells are a specialized subset of memory T cells that reside in tissues and do not recirculate. The presence of **RORA**, **IL7R**, and **ITK** suggests a tissue-resident phenotype, while **CD27** indicates a memory-associated marker. **CXCR3** and **CCL5** are associated with tissue homing and retention.

### Summary:
The most likely identity of this cluster is **CD8+ T cells**, with the top three subtypes being:
1. CD8+ Effector Memory T Cells (TEM)
2. CD8+ Cytotoxic T Cells (CTLs)
3. CD8+ Tissue-Resident Memory T Cells (TRM)

Further confirmation could be achieved by analyzing other contextual data, such as the sample's microenvironment, additional gene expression patterns, or protein-level validation.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: CD8 Memory_2</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>CD8+ Effector Cytotoxic T Cells</td>
                    <td>Hallmark genes of cytotoxic T cells (GZMH, GZMK, GZMB, GZMA, PRF1, GNLY, NKG7, CD8A) are present, along with chemokine secretion activity (CCL5, CCL4, CCL3L3) and transcription factors/immune checkpoint markers (EOMES, TIGIT) associated with effector CD8+ T cells.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Natural Killer (NK) Cells</td>
                    <td>Classic markers of NK cells (KLRG1, NKG7, GNLY, GZMB, GZMA, GZMH, PRF1, FGFBP2, CST7) are expressed, including S1PR5 for tissue-resident/circulating NK cells, and FCRL6/XCL2 associated with NK cell populations.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Tissue-Resident Cytotoxic T Cells or NK T Cells</td>
                    <td>Markers like ITGAL (CD11a) and TIGIT suggest tissue residency or immune checkpoint features. Transcription factors EOMES and BATF can be expressed in tissue-resident cytotoxic lymphocytes, and TRGC2 suggests gamma-delta T cells, which are often tissue-resident and cytotoxic.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided marker genes, this cell cluster is highly likely to represent **cytotoxic lymphocytes**, specifically **cytotoxic T cells or natural killer (NK) cells**. Many of the listed genes are characteristic of cytotoxic activity, immune regulation, and effector functions. Below are the top 3 most likely detailed subtypes:

---

### **1. CD8+ Effector Cytotoxic T Cells**
   - **Key evidence:**
     - Marker genes such as **GZMH, GZMK, GZMB, GZMA, PRF1, GNLY, NKG7, CD8A** are hallmark genes of cytotoxic T cells.
     - **CCL5, CCL4, CCL3L3** indicate chemokine secretion activity commonly seen in activated CD8+ T cells.
     - **EOMES and TIGIT** are transcription factors and immune checkpoint markers associated with differentiation and regulation of effector CD8+ T cells.
   - These cells are likely a population of mature, cytotoxic CD8+ T cells involved in immune defense, particularly against pathogens or tumor cells.

---

### **2. Natural Killer (NK) Cells**
   - **Key evidence:**
     - Genes such as **KLRG1, NKG7, GNLY, GZMB, GZMA, GZMH, PRF1, FGFBP2, CST7** are classic markers of NK cells, which are innate cytotoxic lymphocytes.
     - **S1PR5** is a marker of tissue-resident or circulating NK cells.
     - **FCRL6** and **XCL2** are also associated with NK cell populations.
   - This cluster could represent a subset of NK cells, potentially **mature or cytotoxic NK cells**, given the expression of cytotoxic granule genes and markers of activation.

---

### **3. Tissue-Resident Cytotoxic T Cells or NK T Cells**
   - **Key evidence:**
     - Markers like **ITGAL (CD11a)** and **TIGIT** suggest tissue residency or immune checkpoint features.
     - **EOMES** and **BATF** are transcription factors that can be expressed in tissue-resident cytotoxic lymphocytes.
     - **TRGC2** suggests the presence of gamma-delta T cells, which are often tissue-resident and can exhibit cytotoxic functions.
   - This cluster could represent **tissue-resident cytotoxic T cells** or **NK T cells**, which are specialized subsets of T cells with innate-like properties.

---

### Conclusion:
The top 3 most likely subtypes for this cluster are:
1. CD8+ Effector Cytotoxic T Cells
2. Natural Killer (NK) Cells
3. Tissue-Resident Cytotoxic T Cells or NK T Cells

Further confirmation could be achieved by examining the expression of additional markers such as CD3 (T cell marker) or CD56 (NK cell marker), as well as functional assays or flow cytometry.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: CD8 Naive</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>CD8+ Naïve T Cells</td>
                    <td>Co-expression of CD8A/CD8B and CCR7 suggests a naïve T cell phenotype, supported by LEF1 and TCF7 associated with early T cell development and naïve states.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>CD8+ Effector Memory T Cells</td>
                    <td>Presence of CD27, a marker for memory T cells, along with CD8A/CD8B, indicates effector memory T cells involved in rapid responses.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>CD8+ Cytotoxic T Cells</td>
                    <td>RUNX2 and PRKCA are associated with cytotoxic activity, and GRAP2 is involved in T cell receptor signaling, suggesting a cytotoxic phenotype.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the marker genes provided, this cell cluster is most likely to represent **T cells**, specifically **CD8+ T cells**, due to the presence of prominent T cell markers such as **CD8A, CD8B, CD3D, CD3E, CD3G**, and **CCR7**. Additionally, the presence of **LEF1, BCL11B, and TCF7** supports the identification of T cells, as these are key transcription factors involved in T cell development and function.

Here are the top 3 most likely detailed subtypes for this cluster:

---

### 1. **CD8+ Naïve T Cells**
   - **Key markers:** CD8A, CD8B, CCR7, LEF1, TCF7.
   - **Reasoning:** The co-expression of **CD8A/CD8B** (cytotoxic T cell markers) and **CCR7** (a homing receptor for lymphoid tissues) suggests a naïve T cell phenotype. **LEF1** and **TCF7** are also associated with early T cell development and naïve states.

---

### 2. **CD8+ Effector Memory T Cells**
   - **Key markers:** CD8A, CD8B, CD27, PRKCA, TXK.
   - **Reasoning:** The presence of **CD27**, a marker for memory T cells, along with **CD8A/CD8B**, indicates effector memory T cells. These cells are typically involved in rapid responses to previously encountered antigens.

---

### 3. **CD8+ Cytotoxic T Cells**
   - **Key markers:** CD8A, CD8B, RUNX2, PRKCA, GRAP2.
   - **Reasoning:** **RUNX2** and **PRKCA** are associated with cytotoxic activity, while **GRAP2** is involved in T cell receptor signaling. This suggests a cytotoxic phenotype, likely activated or primed for immune responses.

---

### Additional Notes:
- Some marker genes, such as **RUNX2**, are more commonly associated with bone development, but their expression in immune cells has been noted in certain contexts, such as T cell differentiation or activation.
- If this cluster is derived from a pathological sample (e.g., leukemia), further investigation into aberrant expression of these markers might be warranted.

If you have additional information about the experimental context (e.g., healthy vs. diseased bone marrow, single-cell RNA-seq data, or clustering annotations), it could help refine the subtype identification further.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: GMP</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Promyelocytes or Myeloblasts (Neutrophil Precursors)</td>
                    <td>Key markers (ELANE, PRTN3, MPO, AZU1, CTSG, MS4A3) are highly characteristic of developing neutrophils at this stage, encoding specific granule proteins and indicating proliferating myeloid cells.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Proliferative Myeloid Progenitors (e.g., GMPs - Granulocyte-Monocyte Progenitors)</td>
                    <td>Key markers (TOP2A, CDK1, MKI67, TPX2, MCM2, MCM6, UBE2C) are associated with cell cycle progression and proliferation, indicating actively dividing upstream progenitor cells like GMPs.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Metamyelocytes or Band Neutrophils (Late Neutrophil Precursors)</td>
                    <td>Key markers (RETN, RNASE2, RNASE3, SERPINB10) are expressed in more mature neutrophil precursors, representing later stages in neutrophil differentiation.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided marker genes, the cell cluster you are analyzing likely corresponds to a population of **myeloid lineage cells**, specifically **neutrophil precursors** or other proliferative progenitor cells in the bone marrow. Here’s the reasoning and the top 3 most likely subtypes:

### 1. **Promyelocytes or Myeloblasts (Neutrophil Precursors):**
   - **Key markers:** ELANE, PRTN3, MPO, AZU1, CTSG, MS4A3.
   - These genes are highly characteristic of developing neutrophils (granulocytes) in the bone marrow, particularly at the promyelocyte or myeloblast stage. For example:
     - **ELANE (elastase), PRTN3 (proteinase 3), MPO (myeloperoxidase), CTSG (cathepsin G):** Encode granule proteins specific to neutrophil development.
     - **MS4A3:** A marker of proliferating myeloid cells, particularly neutrophil precursors.

### 2. **Proliferative Myeloid Progenitors (e.g., GMPs - Granulocyte-Monocyte Progenitors):**
   - **Key markers:** TOP2A, CDK1, MKI67, TPX2, MCM2, MCM6, UBE2C.
   - These genes are associated with cell cycle progression and proliferation, indicating that this cluster includes actively dividing cells. Granulocyte-Monocyte Progenitors (GMPs) are a likely candidate, as they are an upstream progenitor population that gives rise to neutrophil precursors.

### 3. **Metamyelocytes or Band Neutrophils (Late Neutrophil Precursors):**
   - **Key markers:** RETN, RNASE2, RNASE3, SERPINB10.
   - These genes are expressed in more mature neutrophil precursors, such as metamyelocytes or band neutrophils, which are later stages in the neutrophil differentiation pathway.

### Additional Notes:
- The presence of proliferation markers (e.g., MKI67, TOP2A, CDK1) suggests that this cluster is actively dividing, which aligns with early to mid-stages of neutrophil development.
- Some markers like IGFBP2 and CLEC11A could also indicate involvement in bone marrow stromal interactions or hematopoietic support.

### Conclusion:
The top 3 most likely subtypes for this cell cluster are:
1. **Promyelocytes or Myeloblasts (early neutrophil precursors).**
2. **Granulocyte-Monocyte Progenitors (GMPs).**
3. **Metamyelocytes or Band Neutrophils (late neutrophil precursors).**

The exact subtype depends on the relative expression of these markers and their differentiation stage.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: HSC</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Hematopoietic Stem Cells (HSCs)</td>
                    <td>These are multipotent, self-renewing stem cells, and the expression of critical transcription factors like HOXA9, MEIS1, and GATA2 is characteristic of HSCs.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Multipotent Progenitor Cells (MPPs)</td>
                    <td>MPPs are downstream of HSCs, retain multilineage differentiation potential, and the overlap of markers with HSCs, including HOXA7 and HOXA9, suggests this possibility.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Common Myeloid Progenitors (CMPs)</td>
                    <td>CMPs are committed progenitors for myeloid lineages, and the expression of genes like GATA2 and TFPI suggests this cluster could represent CMPs.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided marker genes, the cell cluster you are analyzing is most likely associated with hematopoietic stem and progenitor cells (HSPCs) or early progenitors found in human bone marrow. The marker genes include several well-known genes associated with hematopoietic stem/progenitor cells and their regulation, such as **CD34**, **HOXA9**, **HOXA7**, **GATA2**, **MEIS1**, **ERG**, **PBX1**, and **BAALC**. These genes are commonly expressed in early hematopoietic cells and are involved in maintaining stemness, self-renewal, and differentiation potential.

### Top 3 Most Likely Subtypes:
1. **Hematopoietic Stem Cells (HSCs):**
   - **Key markers:** CD34, GATA2, HOXA9, MEIS1, PBX1, ERG, ZNF521, BAALC, HLF.
   - These cells are multipotent, self-renewing stem cells that give rise to all blood cell lineages. The expression of transcription factors like HOXA9, MEIS1, and GATA2, which are critical for stem cell maintenance and differentiation, is characteristic of HSCs.

2. **Multipotent Progenitor Cells (MPPs):**
   - **Key markers:** CD34, HOXA7, HOXA9, ERG, GATA2, ZNF521, BAALC, HLF.
   - MPPs are downstream of HSCs and retain multilineage differentiation potential but lack long-term self-renewal capacity. The overlap of markers with HSCs and the presence of genes like HOXA7 and HOXA9 suggest these could be MPPs.

3. **Common Myeloid Progenitors (CMPs):**
   - **Key markers:** CD34, GATA2, ZNF521, BAALC, TFPI, SPINK2, ANGPT1.
   - CMPs are committed progenitors that give rise to myeloid lineages (e.g., granulocytes, monocytes, erythrocytes, and megakaryocytes). The expression of genes like GATA2 (important for myeloid lineage differentiation) and TFPI (associated with megakaryocyte and platelet function) suggests this cluster could represent CMPs.

### Summary:
The cluster is most likely a population of early hematopoietic cells, with the top 3 subtypes being:
1. Hematopoietic Stem Cells (HSCs).
2. Multipotent Progenitor Cells (MPPs).
3. Common Myeloid Progenitors (CMPs).

Further analysis, such as functional assays or lineage-specific gene expression, would help confirm the exact identity of the cluster.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: LMPP</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Hematopoietic Stem/Progenitor Cells (HSPCs)</td>
                    <td>The presence of markers like CD34, PROM1 (CD133), HOXA7, BAALC, and ERG strongly suggests multipotent or early progenitor cells within the hematopoietic lineage.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Mast Cell Precursors</td>
                    <td>The co-expression of CPA3, KIT (CD117), and HPGDS strongly points to mast cell precursors, which are derived from hematopoietic progenitors.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Endothelial Progenitor Cells (EPCs)</td>
                    <td>The expression of angiogenesis-related markers (e.g., EGFL7, ANGPT1, MDK) alongside CD34 suggests an endothelial lineage bias, likely representing endothelial progenitor cells.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided marker genes, the cell cluster appears to be associated with progenitor or stem cell populations in the human bone marrow, potentially with a bias toward hematopoietic origins. Below are the top three most likely detailed subtypes based on the marker genes:

---

### 1. **Hematopoietic Stem/Progenitor Cells (HSPCs):**
   - **Key supporting markers:** 
     - **CD34:** A well-established marker for hematopoietic stem and progenitor cells.
     - **PROM1 (CD133):** Often co-expressed with CD34 in early hematopoietic stem and progenitor cells.
     - **HOXA7:** A transcription factor involved in hematopoiesis and stem cell regulation.
     - **BAALC:** Frequently expressed in early hematopoietic progenitors and associated with stemness.
     - **ERG:** A transcription factor critical for hematopoietic stem cell maintenance.

   - **Rationale:** The presence of these markers strongly suggests that this cluster contains multipotent or early progenitor cells within the hematopoietic lineage.

---

### 2. **Mast Cell Precursors:**
   - **Key supporting markers:** 
     - **CPA3 (Carboxypeptidase A3):** A hallmark marker of mast cells and their precursors.
     - **HPGDS (Hematopoietic Prostaglandin D Synthase):** Enriched in mast cells and involved in prostaglandin metabolism.
     - **KIT (CD117):** A receptor tyrosine kinase that is highly expressed in mast cells and their precursors.
     - **SPARC:** Known to be expressed in mast cells and involved in extracellular matrix interactions.

   - **Rationale:** The co-expression of CPA3, KIT, and HPGDS strongly points to mast cell precursors, which are derived from hematopoietic progenitors.

---

### 3. **Endothelial Progenitor Cells (EPCs):**
   - **Key supporting markers:** 
     - **EGFL7 (Epidermal Growth Factor-Like Domain 7):** A marker of endothelial progenitors and involved in vascular development.
     - **ANGPT1 (Angiopoietin-1):** A key regulator of angiogenesis and endothelial cell function.
     - **MDK (Midkine):** A growth factor associated with endothelial progenitors and angiogenesis.
     - **SPARC:** Involved in extracellular matrix remodeling, often expressed in endothelial cells.
     - **CD34:** Also found on endothelial progenitors, in addition to hematopoietic progenitors.

   - **Rationale:** The expression of angiogenesis-related markers (e.g., EGFL7, ANGPT1) alongside CD34 suggests an endothelial lineage bias, likely representing endothelial progenitor cells.

---

### Summary:
The top three most likely subtypes for this cell cluster are:
1. **Hematopoietic Stem/Progenitor Cells (HSPCs).**
2. **Mast Cell Precursors.**
3. **Endothelial Progenitor Cells (EPCs).**

Further analysis, such as clustering with additional markers or functional validation, would help refine the subtype identification.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: MAIT</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>CD8+ Effector Memory T Cells (TEM)</td>
                    <td>Supported by granzyme genes (GZMK, GZMA, CTSW) for cytotoxicity, CD8A for CD8+ T cells, KLRG1/IL7R for effector memory, and PRDM1 for terminal differentiation.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Innate-like T Cells (e.g., MAIT or γδ T Cells)</td>
                    <td>Indicated by TRGC2 for γδ T cells, KLRB1 (CD161) for innate-like T cells, IL18RAP/NCR3 for innate immune responses, and RORA.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Natural Killer (NK) Cells</td>
                    <td>Supported by NK cell markers (KLRG1, NCR3, KLRB1, S1PR5), cytotoxic genes (GZMK, GZMA, CST7), and transcription factors ID2/PRDM1 important for NK cell function.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the marker genes provided, this cell cluster most likely corresponds to a subtype of **T cells** or **natural killer (NK) cells** in the human bone marrow. These markers suggest a population of cytotoxic lymphocytes with features of innate-like or adaptive immune cells. Below are the top three most likely detailed subtypes:

---

### 1. **CD8+ Effector Memory T Cells (TEM)**
   - **Supporting marker genes**:  
     - **GZMK, GZMA, CTSW**: Granzyme genes associated with cytotoxic activity.  
     - **CD8A**: Marker for CD8+ T cells.  
     - **KLRG1, IL7R**: Markers of effector memory T cells.  
     - **CCL5, CCL3L3**: Chemokines involved in migration and immune response.  
     - **PRDM1 (Blimp-1)**: Transcription factor associated with terminal differentiation of effector T cells.  

   - **Interpretation**: These cells are likely cytotoxic CD8+ T cells in an effector memory state, which are involved in immune surveillance and rapid responses to previously encountered antigens.

---

### 2. **Innate-like T Cells (e.g., MAIT or γδ T Cells)**
   - **Supporting marker genes**:  
     - **TRGC2**: γδ T-cell receptor gene, specific to γδ T cells.  
     - **KLRB1 (CD161)**: Expressed on innate-like T cells, including mucosal-associated invariant T (MAIT) cells and γδ T cells.  
     - **IL18RAP, NCR3**: Associated with innate-like immune responses.  
     - **RORA**: A transcription factor linked to innate-like lymphocytes.  

   - **Interpretation**: These cells may represent γδ T cells or MAIT cells, which have innate immune functions and are enriched in tissues and bone marrow.

---

### 3. **Natural Killer (NK) Cells**
   - **Supporting marker genes**:  
     - **KLRG1, NCR3, KLRB1, S1PR5**: Markers commonly expressed on NK cells.  
     - **GZMK, GZMA, CST7**: Associated with cytotoxic function in NK cells.  
     - **SH2D1A**: Linked to NK cell signaling.  
     - **ID2, PRDM1**: Transcription factors important for NK cell development and function.  

   - **Interpretation**: This cluster could represent NK cells, particularly a subset of mature or cytotoxic NK cells that are involved in innate immunity.

---

### Summary of Likely Subtypes:
1. CD8+ Effector Memory T Cells (TEM).  
2. Innate-like T Cells (e.g., MAIT or γδ T Cells).  
3. Natural Killer (NK) Cells.

Further classification can be refined with additional data, such as protein expression (e.g., flow cytometry markers like CD3 for T cells or CD56 for NK cells) or functional assays.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: Memory B</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Memory B Cells</td>
                    <td>Characterized by expression of CD19, CD20 (MS4A1), CD22, BANK1, and FCRL family members, including FCRL2 and FCRL5, along with TNFRSF13B and TNFRSF13C.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Naïve B Cells</td>
                    <td>Shares markers with memory B cells but distinguished by the expression of PAX5 and EBF1, suggesting a less differentiated state, and absence of plasma cell-specific markers.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Marginal Zone B Cells</td>
                    <td>Identified by high expression of FCRL family members (e.g., FCRL2, FCRL5) and BANK1, along with typical B cell markers, and absence of plasma cell markers.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the marker genes provided, the cell cluster is most likely a **B cell population**. The presence of key B cell markers such as **MS4A1 (CD20)**, **CD19**, **CD22**, **CD79A**, **CD79B**, **PAX5**, and **FCRL1-5** strongly indicates a B cell identity. Additionally, the expression of transcription factors **POU2AF1** and **SPIB**, and other B cell-associated markers like **BLK**, **BANK1**, and **EBF1**, further supports this conclusion. Below are the top 3 most likely detailed subtypes of this cluster:

### 1. **Memory B Cells**
   - **Key markers supporting this subtype**: CD19, CD22, CD79A, CD79B, MS4A1 (CD20), FCRL2, FCRL5, and BANK1.
   - Memory B cells are characterized by the expression of surface markers such as CD19, CD20 (MS4A1), and CD22, along with other signaling molecules like BANK1 and FCRL family members. The presence of TNFRSF13B (TACI) and TNFRSF13C (BAFF-R) also supports a role in the survival and activation of memory B cells.

### 2. **Naïve B Cells**
   - **Key markers supporting this subtype**: CD19, CD20 (MS4A1), CD79A, CD79B, PAX5, and EBF1.
   - Naïve B cells share many markers with memory B cells but are typically less differentiated. The expression of PAX5 and EBF1 suggests a more immature or naïve B cell state. The absence of plasma cell-specific markers like XBP1 or PRDM1 (BLIMP1) also supports a non-plasmacytic B cell identity.

### 3. **Marginal Zone B Cells**
   - **Key markers supporting this subtype**: CD19, CD20 (MS4A1), CD22, CD79A, CD79B, and FCRL5.
   - Marginal zone B cells are a specialized subset of mature B cells that are enriched in the spleen and can also circulate in the blood. The high expression of FCRL family members (e.g., FCRL2, FCRL5) and BANK1, along with the absence of plasma cell markers, suggests a marginal zone B cell identity.

### Additional Notes:
- The lack of plasma cell-specific markers (e.g., PRDM1, XBP1, IRF4) indicates that these are not plasma cells.
- The presence of **AIM2**, **TLR10**, and **CD40** suggests a role in immune signaling and activation, which is consistent with activated or antigen-experienced B cells.

In conclusion, this cluster is most likely a **B cell population**, with the top 3 likely subtypes being **memory B cells**, **naïve B cells**, and **marginal zone B cells**. Further analysis, such as pathway enrichment or surface protein validation, could help refine the subtype identification.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: NK</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Cytotoxic NK cells (CD56^dim NK cells)</td>
                    <td>Strongly associated with marker genes like KLRF1, PRF1, GZMB, GNLY, NKG7, KLRD1, CD160, FGFBP2, and SH2D1B, and express granule-associated proteins mediating cell killing.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Adaptive or Memory-like NK cells</td>
                    <td>Associated with marker genes such as FCGR3A (CD16), SH2D1B, TBX21, IL2RB, FCRL6, and S1PR5, exhibiting enhanced effector functions and long-term persistence.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Innate-like T cells (e.g., NKT cells or γδ T cells)</td>
                    <td>Suggested by marker genes such as TRDC, XCL2, IL18RAP, CD247, and GZMA, indicating a possible innate-like T cell population with cytotoxic and regulatory roles.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided marker genes, this cluster is likely a subset of **natural killer (NK) cells** or cytotoxic lymphocytes. These cells are part of the immune system and play a key role in recognizing and killing virally infected or tumor cells. The specific marker genes strongly suggest cytotoxic functionality and NK cell identity. Here's a detailed breakdown of the top 3 most likely subtypes:

---

### **1. Cytotoxic NK cells (CD56^dim NK cells):**
   - **Key evidence:** 
     - Marker genes such as **KLRF1, PRF1, GZMB, GNLY, NKG7, KLRD1, CD160, FGFBP2**, and **SH2D1B** are strongly associated with cytotoxic NK cells.
     - These cells are highly cytotoxic and express granule-associated proteins like **granzyme B (GZMB)**, **perforin (PRF1)**, and **granulysin (GNLY)**, which mediate cell killing.
     - **FGFBP2** is a known marker of highly cytotoxic NK cells.
   - **Function:** These cells are specialized in killing virally infected cells and tumor cells via cytotoxic mechanisms.

---

### **2. Adaptive or Memory-like NK cells:**
   - **Key evidence:**
     - Marker genes such as **FCGR3A (CD16), SH2D1B, TBX21, IL2RB, FCRL6, and S1PR5** are associated with adaptive or memory-like NK cells.
     - These NK cells exhibit enhanced effector functions and can persist long-term, resembling features of adaptive immunity.
     - **TBX21 (T-bet)** is a transcription factor that defines terminally differentiated NK cells.
   - **Function:** These NK cells exhibit enhanced responses upon restimulation and are often found in chronic infections or cancer settings.

---

### **3. Innate-like T cells (e.g., NKT cells or γδ T cells):**
   - **Key evidence:**
     - Marker genes such as **TRDC, XCL2, IL18RAP, CD247, and GZMA** suggest a possible innate-like T cell population, such as natural killer T (NKT) cells or γδ T cells.
     - **TRDC** indicates the presence of γδ T cells, which are innate-like T cells with cytotoxic functions.
     - **XCL2** and **IL18RAP** are markers associated with innate-like lymphocytes.
   - **Function:** These cells bridge innate and adaptive immunity, with cytotoxic and regulatory roles.

---

### Summary:
The top 3 most likely subtypes for this cluster are:
1. **Cytotoxic NK cells (CD56^dim NK cells)**  
2. **Adaptive or Memory-like NK cells**  
3. **Innate-like T cells (e.g., NKT cells or γδ T cells)**  

Further confirmation could be achieved by integrating other data modalities, such as protein expression (e.g., flow cytometry or CITE-seq for CD56, CD16, and CD3) or by examining additional transcriptional programs.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: Naive B</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Naïve B Cells</td>
                    <td>Key marker genes like CD19, CD22, CD72, MS4A1, CD79A, CD79B, PAX5, VPREB3, TCL1A are highly expressed in immature or naïve B cells, and IGHD is indicative of this stage.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Memory B Cells</td>
                    <td>Genes such as CD19, MS4A1, CD40, CD72, CD83, BANK1, FCRL2, FCRL3, FCRL1, FCRLA are associated with antigen-experienced B cells, with CD40 and CD83 being particularly indicative of memory B cells.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Germinal Center B Cells</td>
                    <td>Markers like PAX5, CD19, CD79A, CD79B, BCL7A, SWAP70, RASGRP3, BLNK, TLR10 are associated with B cells actively participating in germinal center reactions, and genes like BCL7A and SWAP70 suggest involvement in these processes.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided marker genes, this cell cluster is most likely associated with **B cells**, as many of the genes listed are hallmark markers of B cell identity, differentiation, and function. To refine the analysis further, we can identify the **most likely subtypes of B cells** based on the expression of these markers.

### Top 3 Most Likely Detailed Subtypes:

1. **Naïve B Cells**:
   - **Key marker genes**: CD19, CD22, CD72, MS4A1 (encodes CD20), CD79A, CD79B, PAX5, VPREB3, TCL1A.
   - These markers are highly expressed in immature or naïve B cells that have not yet been activated. The presence of IGHD (IgD) is also indicative of naïve B cells, as IgD is a characteristic surface immunoglobulin of this stage.

2. **Memory B Cells**:
   - **Key marker genes**: CD19, MS4A1, CD40, CD72, CD83, BANK1, FCRL2, FCRL3, FCRL1, FCRLA.
   - These genes are associated with antigen-experienced B cells that have differentiated into memory B cells. CD40 and CD83 are particularly indicative of memory B cells, as they are upregulated during the transition from naïve to memory stages.

3. **Germinal Center B Cells**:
   - **Key marker genes**: PAX5, CD19, CD79A, CD79B, BCL7A, SWAP70, RASGRP3, BLNK, TLR10.
   - These markers are associated with B cells actively participating in germinal center reactions, where they undergo somatic hypermutation and class-switch recombination. The presence of genes like BCL7A and SWAP70 suggests involvement in germinal center processes.

### Supporting Evidence:
- The expression of **HLA-DOA** and **HLA-DOB** suggests antigen presentation, a feature of B cells in general.
- **MS4A1 (CD20)** is a classic B cell marker found across multiple B cell subtypes.
- The presence of **TNFRSF13C (BAFF receptor)** indicates involvement in B cell survival and maturation, consistent with naïve, memory, or germinal center B cells.

### Conclusion:
This cluster is most likely composed of **B cells**, with the top three subtypes being:
1. Naïve B cells.
2. Memory B cells.
3. Germinal center B cells.

Further clarification can be achieved by analyzing the expression levels of these genes and integrating additional data, such as surface protein markers or functional assays.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: Plasmablast</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>IgG-secreting plasma cells</td>
                    <td>Marker genes indicating IgG production include IGHG1, IGHG2, IGHG3, IGHG4, and JCHAIN. These plasma cells are specialized in secreting IgG antibodies.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>IgA-secreting plasma cells</td>
                    <td>Marker genes such as IGHA1, IGHA2, and JCHAIN suggest the presence of IgA-secreting plasma cells. These cells are important for mucosal immunity.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>IgM-secreting plasma cells</td>
                    <td>The presence of IGHM suggests that some cells in this cluster may be IgM-secreting plasma cells. IgM is the first antibody produced during an immune response.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>The marker genes provided strongly suggest that this cell cluster is composed of **plasma cells**, which are terminally differentiated B cells specialized in antibody production. Plasma cells are characterized by the expression of immunoglobulin genes (e.g., IGHG2, IGHG3, IGHA1, IGHM, IGLC2, IGKC, JCHAIN) and other markers associated with antibody secretion and endoplasmic reticulum stress (e.g., MZB1, TXNDC5, FKBP11, PRDX4). 

Here are the **top 3 most likely detailed subtypes** of plasma cells based on the marker genes:

### 1. **IgG-secreting plasma cells**
   - Marker genes indicating IgG production include **IGHG1, IGHG2, IGHG3, IGHG4, and JCHAIN**. These plasma cells are specialized in secreting IgG antibodies, which are the most abundant immunoglobulin in circulation and play a key role in adaptive immunity.

### 2. **IgA-secreting plasma cells**
   - Marker genes such as **IGHA1, IGHA2, and JCHAIN** suggest the presence of IgA-secreting plasma cells. These cells are important for mucosal immunity and are often found in tissues with high exposure to environmental antigens, such as the gastrointestinal tract.

### 3. **IgM-secreting plasma cells**
   - The presence of **IGHM** suggests that some cells in this cluster may be IgM-secreting plasma cells. IgM is the first antibody produced during an immune response and plays a critical role in early pathogen neutralization.

### Additional Notes:
- Other marker genes like **SDC1 (syndecan-1)** and **TNFRSF17 (BCMA)** are canonical plasma cell markers.
- Genes associated with the unfolded protein response and antibody production (e.g., **MZB1, TXNDC5, FKBP11, PRDX4**) reflect the high secretory activity of plasma cells.
- The presence of light chain genes (**IGKC, IGLC2, IGLC3**) further supports the identification of plasma cells.

This cluster is most likely composed of a mix of plasma cell subtypes, with IgG-secreting plasma cells being the most abundant in the bone marrow under normal conditions.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: Prog_B 1</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Pro-B Cells</td>
                    <td>Pro-B cells are the most likely subtype due to the presence of RAG1, RAG2, and DNTT, which are critical for early recombination events.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Pre-B Cells</td>
                    <td>Pre-B cells are a later stage of B cell development, following successful rearrangement of the IgH chain, expressing the pre-BCR including IGLL1 and VPREB1.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Immature B Cells</td>
                    <td>Immature B cells are the next stage after pre-B cells, characterized by successful rearrangement of both heavy and light chain genes and expression of a functional BCR, with high CD24 and CD38.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided marker genes, this cell cluster is most likely associated with early B cell development in the human bone marrow. The marker genes include several key indicators of B cell progenitors and precursors, such as **DNTT, RAG1, RAG2, IGLL1, VPREB1, VPREB3, CD24, EBF1, and FLT3**, which are critical for lymphoid lineage specification and B cell receptor (BCR) rearrangement during B cell maturation.

Here are the **top 3 most likely detailed subtypes** of this cell cluster:

### 1. **Pro-B Cells**
   - **Key markers:** DNTT, RAG1, RAG2, IGLL1, VPREB1, EBF1, FLT3, CD24
   - **Description:** Pro-B cells represent an early stage of B cell development in the bone marrow. These cells are actively undergoing immunoglobulin heavy chain (IgH) rearrangement, which is mediated by RAG1 and RAG2. DNTT (TdT) is involved in adding nucleotide diversity during Ig gene recombination. EBF1 is a transcription factor essential for B cell lineage commitment.

### 2. **Pre-B Cells**
   - **Key markers:** IGLL1, VPREB1, VPREB3, CD24, CD38
   - **Description:** Pre-B cells are a later stage of B cell development, following successful rearrangement of the IgH chain. These cells express the pre-B cell receptor (pre-BCR), which includes surrogate light chain components such as IGLL1 and VPREB1. CD24 and CD38 are also commonly expressed at this stage.

### 3. **Immature B Cells**
   - **Key markers:** CD24, CD38, MME (CD10), MYB, BAALC
   - **Description:** Immature B cells are the next stage after pre-B cells, characterized by the successful rearrangement of both heavy and light chain genes, leading to the expression of a functional B cell receptor (BCR). CD24 and CD38 are highly expressed, and MME (CD10) is a marker of immature B cells in the bone marrow.

### Summary:
The marker genes strongly suggest that this cluster represents cells in the **early B cell developmental pathway**, specifically **Pro-B cells**, **Pre-B cells**, or **Immature B cells**, with Pro-B cells being the most likely subtype due to the presence of RAG1, RAG2, and DNTT, which are critical for early recombination events.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: Prog_B 2</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Pro-B Cells</td>
                    <td>Key markers like RAG2, VPREB1, IGLL1, and DNTT are critical for immunoglobulin recombination and expression, aligning with the heavy chain rearrangement characteristic of this early B cell development stage.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Pre-B Cells</td>
                    <td>Markers such as VPREB1, IGLL1 (components of the pre-B cell receptor), and MME (CD10) are characteristic of this stage, which involves light chain rearrangement and pre-BCR expression.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Immature B Cells</td>
                    <td>Markers like MME (CD10), CD24, BEST3, and AKAP12 are associated with this final stage of bone marrow B cell development, involved in maturation and preparation for migration.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the marker genes provided, this cell cluster is most likely a population of **developing B cells** in the human bone marrow, as many of the listed genes are characteristic of specific stages of B cell development. Here are the top three most likely subtypes, with reasoning:

---

### 1. **Pro-B Cells**
   - **Key supporting markers**: 
     - *RAG2*, *VPREB1*, *IGLL1*: These genes are critical for the recombination and expression of the immunoglobulin heavy and light chains, which are hallmark features of early B cell development.
     - *DNTT* (Terminal deoxynucleotidyl transferase): A key enzyme involved in generating diversity in the immunoglobulin gene rearrangements during V(D)J recombination.
   - Pro-B cells are an early stage in B cell development, where heavy chain rearrangement occurs, and these markers align with that stage.

---

### 2. **Pre-B Cells**
   - **Key supporting markers**:
     - *VPREB1* (Pre-B lymphocyte protein 1) and *IGLL1* (Immunoglobulin lambda-like polypeptide 1): These are components of the pre-B cell receptor, which is expressed during the pre-B cell stage, following successful heavy chain recombination.
     - *MME* (CD10): A canonical marker of pre-B cells.
     - *DNTT*: While still expressed, its levels begin to decrease as cells transition from pro-B to pre-B stages.
   - Pre-B cells represent a later stage of B cell development, characterized by light chain rearrangement and pre-BCR expression, consistent with these markers.

---

### 3. **Immature B Cells**
   - **Key supporting markers**:
     - *MME* (CD10): Also expressed in immature B cells.
     - *CD24*: A marker of immature B cells, involved in their maturation and trafficking.
     - *BEST3*, *AKAP12*: These genes are associated with cell signaling and adhesion, which are important for immature B cells as they prepare to exit the bone marrow.
   - Immature B cells are the final stage of bone marrow B cell development, prior to their migration to peripheral lymphoid organs.

---

### Summary:
The marker genes strongly suggest that this cluster represents **developing B cells** in the bone marrow. The top three most likely subtypes are:
1. **Pro-B cells**
2. **Pre-B cells**
3. **Immature B cells**

Further confirmation can be obtained by checking for additional stage-specific markers or analyzing the expression levels of these genes in the cluster.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: Prog_DC</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Proliferating Hematopoietic Progenitor Cells (HSPCs)</td>
                    <td>Actively dividing HSPCs, responsible for replenishing blood cell lineages, with high expression of mitotic markers (e.g., MKI67, CDK1, AURKB, PLK1) supporting their proliferative state.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Erythroid Progenitors (Proerythroblasts or Basophilic Erythroblasts)</td>
                    <td>Highly proliferative during differentiation, with markers like FOXM1, TOP2A, MKI67, UBE2C, and CDCA genes frequently expressed during erythroid lineage expansion.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Myeloid Progenitors (e.g., Granulocyte-Macrophage Progenitors or GMPs)</td>
                    <td>Another highly proliferative bone marrow population, with markers such as AXL, MKI67, and TOP2A suggesting dividing myeloid precursors.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>The provided marker genes suggest that the cell cluster you are analyzing is highly enriched in genes associated with cell cycle progression, mitosis, and proliferation. Many of these genes (e.g., **MKI67, AURKB, PLK1, CDK1, TOP2A, BIRC5, FOXM1, KIF11, CENPA**) are classical markers of actively dividing cells, particularly in the context of hematopoiesis. Based on this information, the cell cluster is most likely composed of proliferating cells in the human bone marrow, which could correspond to specific progenitor or precursor populations. Below are the top three most likely detailed subtypes:

### 1. **Proliferating Hematopoietic Progenitor Cells (HSPCs)**
   - These are actively dividing hematopoietic stem and progenitor cells (HSPCs), which are responsible for replenishing all blood cell lineages. The high expression of mitotic markers (e.g., **MKI67, CDK1, AURKB, PLK1**) strongly supports that these cells are in a proliferative state, which is characteristic of progenitor cells during hematopoiesis.

### 2. **Erythroid Progenitors (Proerythroblasts or Basophilic Erythroblasts)**
   - Erythroid progenitors (early-stage erythroid cells) are highly proliferative during their differentiation. Some of the markers in your list, such as **FOXM1, TOP2A, and MKI67**, are frequently expressed during erythroid lineage expansion. Additionally, **UBE2C** and **CDCA genes** are known to be expressed in rapidly dividing erythroid precursors.

### 3. **Myeloid Progenitors (e.g., Granulocyte-Macrophage Progenitors or GMPs)**
   - Myeloid progenitors are another highly proliferative population in the bone marrow. Markers such as **AXL** (associated with myeloid lineage), **MKI67**, and **TOP2A** suggest that these could be dividing myeloid precursors preparing to differentiate into granulocytes or monocytes.

---

### Summary:
Based on the marker gene profile, the top three most likely subtypes for this cell cluster are:
1. Proliferating hematopoietic progenitor cells.
2. Erythroid progenitors (early-stage).
3. Myeloid progenitors (e.g., GMPs).

Further confirmation could be achieved by examining lineage-specific markers (e.g., **GATA1** for erythroid cells, **PU.1** for myeloid cells) or integrating these results with single-cell RNA-seq clustering data.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: Prog_Mk</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Mature Megakaryocytes</td>
                    <td>Key markers like PF4, VWF, ITGA2B, and SELP are hallmark markers of mature megakaryocytes and critical for platelet adhesion and aggregation.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Immature Megakaryocytes (Megakaryocyte Progenitors)</td>
                    <td>Markers such as GATA2, MEIS1, and TAL1 are associated with earlier stages of megakaryocyte development and essential for lineage commitment.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Platelet Precursors (Proplatelets)</td>
                    <td>These are late-stage megakaryocyte derivatives, and the expression of PF4, ITGA2B, and SELP indicates active involvement in platelet production.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>To identify the cell cluster based on the marker genes provided, we need to consider the expression of these genes and their known association with specific cell types in human bone marrow. Based on the list of marker genes, the cluster is most likely associated with **megakaryocytes or platelet precursors** due to the presence of key markers such as **PF4, VWF, ITGA2B, SELP, and GNG11**, which are strongly associated with megakaryocyte lineage and platelet production.

Here are the **top 3 most likely detailed subtypes** for this cell cluster:

### 1. **Mature Megakaryocytes:**
   - **Key markers:** PF4, VWF, ITGA2B, SELP, GNG11, SDPR, TIMP3.
   - These cells are responsible for platelet production in the bone marrow. PF4 (platelet factor 4) and VWF (von Willebrand factor) are hallmark markers of mature megakaryocytes. ITGA2B (integrin alpha-IIb, also known as CD41) and SELP (P-selectin) are critical for platelet adhesion and aggregation.

### 2. **Immature Megakaryocytes (Megakaryocyte Progenitors):**
   - **Key markers:** GATA2, MEIS1, TAL1, ANGPT1, MYCT1.
   - These markers are associated with earlier stages of megakaryocyte development. GATA2 and TAL1 are transcription factors essential for hematopoietic and megakaryocyte lineage commitment. MEIS1 and ANGPT1 also play roles in hematopoiesis and progenitor cell maintenance.

### 3. **Platelet Precursors (Proplatelets):**
   - **Key markers:** PF4, ITGA2B, SELP, GNG11, SDPR, TIMP3.
   - These are late-stage megakaryocyte derivatives that are in the process of forming platelets. The expression of PF4, ITGA2B, and SELP is indicative of cells actively involved in platelet production.

### Additional Notes:
- The presence of genes like **HPGDS, CPA3, and IL1B** may suggest some overlap with mast cells or inflammatory cells, but the overall gene signature strongly points to the megakaryocyte lineage.
- Genes such as **TAL1, GATA2, and MEIS1** are hematopoietic transcription factors that further support the assignment to megakaryocyte or platelet-related cells.

### Conclusion:
The most likely identity of this cell cluster is **megakaryocytes or their precursors**. The top three subtypes are:
1. Mature megakaryocytes.
2. Immature megakaryocytes (progenitors).
3. Platelet precursors (proplatelets).</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: Prog_RBC</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Mature Erythrocytes (Red Blood Cells)</td>
                    <td>Marker genes like HBA1, HBA2, HBB, HBD, HBM encode hemoglobin components, and ANK1, SPTA1, SPTBN2, SLC4A1 are critical for RBC membrane integrity.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Late Erythroid Progenitors (Orthochromatic Erythroblasts/Reticulocytes)</td>
                    <td>Genes such as ALAS2, KLF1, AHSP, and GYPA indicate late-stage erythroid progenitors, with ALAS2 essential for heme biosynthesis, KLF1 a key erythropoiesis transcription factor, and GYPA a marker of late erythroid differentiation.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Early Erythroid Progenitors (Proerythroblasts/Basophilic Erythroblasts)</td>
                    <td>The presence of SOX6, KLF1, and TRIM10 suggests early erythroid progenitors, with SOX6 involved in erythroid differentiation regulation and TRIM10 expressed in early erythroid cells.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the list of marker genes provided, the cell cluster is most likely part of the erythroid lineage in human bone marrow. These genes are highly characteristic of erythroid progenitors and erythrocytes, with many of them being involved in hemoglobin production, red blood cell (RBC) membrane structure, and erythropoiesis.

Here are the top 3 most likely detailed subtypes:

1. **Mature Erythrocytes (Red Blood Cells)**:
   - Marker genes such as **HBA1, HBA2, HBB, HBD, HBM, AHSP, SLC4A1, ANK1, SPTA1, and SPTBN2** are strongly associated with mature erythrocytes. These genes encode components of hemoglobin (HBA1, HBA2, HBB, HBD, HBM) and structural proteins critical for RBC membrane integrity (ANK1, SPTA1, SPTBN2, and SLC4A1).

2. **Late Erythroid Progenitors (Orthochromatic Erythroblasts/Reticulocytes)**:
   - Genes like **ALAS2, KLF1, AHSP, and GYPA** suggest late-stage erythroid progenitors or reticulocytes, which are precursors to mature erythrocytes. **ALAS2** is essential for heme biosynthesis, and **KLF1** is a key transcription factor for erythropoiesis. **GYPA** (glycophorin A) is a marker of late erythroid differentiation.

3. **Early Erythroid Progenitors (Proerythroblasts/Basophilic Erythroblasts)**:
   - The presence of genes like **SOX6, KLF1, and TRIM10** suggests early erythroid progenitors. **SOX6** is involved in the regulation of erythroid differentiation, and **TRIM10** is expressed in early erythroid cells. These cells are still undergoing active transcription and translation to prepare for hemoglobin production and maturation.

### Summary:
The cell cluster is part of the erythroid lineage, and the top 3 most likely subtypes are:
1. Mature Erythrocytes (RBCs)
2. Late Erythroid Progenitors (Orthochromatic Erythroblasts/Reticulocytes)
3. Early Erythroid Progenitors (Proerythroblasts/Basophilic Erythroblasts)</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: Treg</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Effector/Activated CD4+ T cells (e.g., T helper cells, Th1/Th2/Th17 subsets)</td>
                    <td>Key evidence includes markers like GATA3 (Th2 cells), IL32 (inflammatory cytokine), LEF1, CD27, CD5 (mature/activated T cells), and ITK/LCK (TCR signaling).</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Regulatory T cells (Tregs)</td>
                    <td>Key evidence includes IL2RA (CD25) (hallmark marker), TIGIT (enriched in Tregs, suppressive function), and ITGB1/ITGB7 (cell adhesion/migration consistent with Tregs).</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Cytotoxic CD8+ T cells</td>
                    <td>Key evidence includes TCR complex markers (TRAC, TRBC1, TRBC2, CD3D, CD3E, CD3G), PRDM1 (Blimp-1) (terminally differentiated effector phenotype), and PIK3IP1, RASGRP1, SLFN5 (T cell signaling/cytotoxic functions).</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the marker genes provided, this cell cluster is most likely a subset of **T cells**, as many of the markers are associated with T cell identity and function. The presence of genes like **CD3D, CD3E, CD3G, TRAC, TRBC1, TRBC2, CD2, CD5, CD6, CD27, IL32, GATA3, LCK**, and **ITK** strongly suggest T cell lineage. Additionally, markers like **IL2RA (CD25)** and **TIGIT** indicate potential activation or specific T cell subtypes. Here are the top 3 most likely detailed subtypes:

---

### 1. **Effector/Activated CD4+ T cells (e.g., T helper cells, Th1/Th2/Th17 subsets)**
   - **Key evidence**: 
     - Markers like **GATA3** (associated with Th2 cells), **IL32** (inflammatory cytokine linked to CD4+ T cells), and **LEF1** (transcription factor expressed in T cells).
     - **CD27** and **CD5**, which are expressed on mature and activated T cells.
     - **ITK** and **LCK**, which are critical for T cell receptor (TCR) signaling.
   - These markers suggest a population of activated or effector CD4+ T cells, potentially involved in immune responses.

---

### 2. **Regulatory T cells (Tregs)**
   - **Key evidence**:
     - **IL2RA (CD25)** is a hallmark marker of Tregs, especially when co-expressed with FOXP3 (not listed here but could still be implied).
     - **TIGIT** is another marker enriched in Tregs, associated with their suppressive function.
     - The presence of **ITGB1** and **ITGB7**, which are involved in cell adhesion and migration, is consistent with Tregs trafficking to tissues.
   - This cluster could represent a subset of Tregs, which are critical for maintaining immune tolerance and preventing autoimmunity.

---

### 3. **Cytotoxic CD8+ T cells**
   - **Key evidence**:
     - Markers like **TRAC, TRBC1, TRBC2, CD3D, CD3E, CD3G** are all components of the TCR complex, present in both CD4+ and CD8+ T cells.
     - The presence of **PRDM1 (Blimp-1)** suggests a terminally differentiated effector phenotype, often seen in cytotoxic T cells.
     - **PIK3IP1, RASGRP1, and SLFN5** are associated with T cell signaling and cytotoxic functions.
     - While CD8 itself is not listed, the overall gene expression profile could still align with cytotoxic CD8+ T cells.

---

### Summary
The top 3 most likely subtypes for this cluster are:
1. Effector/Activated CD4+ T cells (e.g., Th1/Th2/Th17 subsets).
2. Regulatory T cells (Tregs).
3. Cytotoxic CD8+ T cells.

Further confirmation could be achieved by checking for additional markers like **FOXP3** (for Tregs) or **CD8A/CD8B** (for cytotoxic T cells), as well as functional assays or protein-level validation.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: cDC2</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>cDC2 (Classical Dendritic Cells Type 2)</td>
                    <td>Most likely due to expression of hallmark cDC2 markers such as CD1C, CLEC10A, and FCER1A, and high expression of HLA class II molecules.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Pre-cDCs (Precursor Dendritic Cells)</td>
                    <td>Suggested by the presence of FLT3, a key marker for dendritic cell precursors, and expression of some HLA genes.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Plasmacytoid Dendritic Cells (pDCs)</td>
                    <td>Some markers like HLA-DRA, CLEC10A, and FCER1A could be expressed, but absence of key pDC-specific genes like IRF7 and GZMB makes it less likely.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the marker genes provided, this cell cluster is most likely a subtype of **dendritic cells (DCs)**, specifically **classical/conventional dendritic cells (cDCs)** or related subtypes. Many of the marker genes are characteristic of antigen-presenting cells, particularly dendritic cells, due to the high expression of **HLA (human leukocyte antigen) genes** (e.g., HLA-DQA1, HLA-DPB1, HLA-DRA) and other immune-related markers like **CD1C, CD1E, CLEC10A, and FCER1A**.

Here are the **top 3 most likely detailed subtypes** of this cluster:

### 1. **cDC2 (Classical Dendritic Cells Type 2)**
   - **Reasoning**: This is the most likely subtype because of the expression of hallmark cDC2 markers such as **CD1C**, **CLEC10A**, and **FCER1A**. cDC2 cells are specialized for antigen presentation and are typically found in human bone marrow and peripheral tissues. They are involved in activating CD4+ T cells and are known for their high expression of HLA class II molecules (e.g., HLA-DQA1, HLA-DPB1, HLA-DRA).
   - **Key markers supporting this subtype**: CD1C, CLEC10A, HLA-DQA1, HLA-DPB1, and other HLA genes.

### 2. **Pre-cDCs (Precursor Dendritic Cells)**
   - **Reasoning**: The presence of **FLT3** (a key marker for dendritic cell precursors) suggests that this cluster could represent precursor dendritic cells, which differentiate into cDC1 or cDC2. Pre-cDCs are found in the bone marrow and express some HLA genes as they prepare to migrate to peripheral tissues and mature.
   - **Key markers supporting this subtype**: FLT3, CD33, HLA genes (e.g., HLA-DQA1, HLA-DRA), and CD74.

### 3. **Plasmacytoid Dendritic Cells (pDCs)**
   - **Reasoning**: While the marker profile strongly favors cDC2, there are a few markers (e.g., **HLA-DRA, CLEC10A, and FCER1A**) that could also be expressed in plasmacytoid dendritic cells. pDCs are known for their role in producing type I interferons during viral infections. However, the absence of key pDC-specific genes like **IRF7** and **GZMB** makes this subtype less likely compared to cDC2.
   - **Key markers supporting this subtype**: HLA-DRA, CLEC10A, and FCER1A.

### Summary of Likely Subtypes:
1. **cDC2** (most likely)
2. **Pre-cDCs**
3. **pDCs** (less likely)

If additional data are available, such as protein expression or functional assays, these could help confirm the subtype more definitively.</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: gdT</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Natural Killer (NK) Cells</td>
                    <td>Hallmark genes of cytotoxic activity (NKG7, GNLY, GZMK, GZMA, GZMH, GZMM, PRF1, CST7) and NK cell-specific receptors/markers (KLRD1, KLRB1, KLRG1, KLRC1, NCR3, S1PR5, FGFBP2) are present.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>γδ T Cells</td>
                    <td>Specific T-cell receptor genes (TRGC1, TRGC2, TRDC) are present, along with markers of activated γδ T cells (LAG3, TBX21) and cytotoxic effector molecules (CCL5, GNLY, PRF1, GZMA, GZMH, GZMM).</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Cytotoxic CD8+ T Cells (Effector or Memory Subtype)</td>
                    <td>Hallmarks of cytotoxic CD8+ T cells (GZMK, GZMA, GZMH, GZMM, PRF1, GNLY, NKG7) are present, along with markers associated with effector/memory CD8+ T cells (TBX21, CCL5, KLRG1, LAG3).</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided marker genes, this cell cluster likely corresponds to a subset of innate or adaptive immune cells, specifically cytotoxic or innate lymphoid-like cells. Here's an interpretation of the top 3 most likely detailed subtypes:

---

### **1. Natural Killer (NK) Cells**
- **Supporting evidence from marker genes:**
  - **NKG7, GNLY, GZMK, GZMA, GZMH, GZMM, PRF1, CST7:** These are hallmark genes of cytotoxic activity, characteristic of NK cells.
  - **KLRD1 (CD94), KLRB1, KLRG1, KLRC1, NCR3:** These genes encode receptors and markers commonly expressed on NK cells.
  - **S1PR5:** A marker of mature NK cells involved in migration.
  - **FGFBP2:** A known NK cell-associated gene.

---

### **2. γδ T Cells**
- **Supporting evidence from marker genes:**
  - **TRGC1, TRGC2, TRDC:** These are T-cell receptor (TCR) genes specific to γδ T cells.
  - **LAG3, TBX21 (T-bet):** These are associated with activated γδ T cells.
  - **CCL5, GNLY, PRF1, GZMA, GZMH, GZMM:** Cytotoxic effector molecules characteristic of γδ T cells.
  - γδ T cells are found in bone marrow and share functional similarities with NK cells, including cytotoxic activity.

---

### **3. Cytotoxic CD8+ T Cells (Effector or Memory Subtype)**
- **Supporting evidence from marker genes:**
  - **GZMK, GZMA, GZMH, GZMM, PRF1, GNLY, NKG7:** Hallmarks of cytotoxic CD8+ T cells.
  - **TBX21 (T-bet):** A transcription factor associated with effector CD8+ T cells.
  - **CCL5:** A chemokine highly expressed by cytotoxic T cells.
  - **KLRG1:** A marker of terminally differentiated CD8+ T cells.
  - **LAG3:** Expressed during activation and exhaustion of CD8+ T cells.

---

### Summary:
- **Most likely subtype:** Natural Killer (NK) Cells
- **Second most likely subtype:** γδ T Cells
- **Third most likely subtype:** Cytotoxic CD8+ T Cells

These subtypes are all cytotoxic immune cells, and further differentiation between them may require additional information, such as TCR sequencing (to confirm γδ T cells) or surface protein expression data (e.g., flow cytometry markers like CD3 for T cells vs. CD56 for NK cells).</pre>
    </details>
</div>

<div class="cluster-section">
    <h2>Cluster: pDC</h2>
    <h3>Top Hypotheses</h3>
    <table>
        <thead>
            <tr>
                <th>Rank</th>
                <th>Predicted Cell Type</th>
                <th>Reasoning</th>
            </tr>
        </thead>
        <tbody>
            
                <tr>
                    <td>1</td>
                    <td>Plasmacytoid Dendritic Cells (pDCs)</td>
                    <td>Supported by canonical markers LILRA4, CLEC4C, and IL3RA, which are highly specific to pDCs and indicate their role in type I interferon production.</td>
                </tr>
                
                <tr>
                    <td>2</td>
                    <td>Pre-dendritic Cells (Pre-DCs)</td>
                    <td>Share key markers like LILRA4 and CLEC4C with pDCs, indicating they are progenitors with significant expression profile overlap, though less differentiated.</td>
                </tr>
                
                <tr>
                    <td>3</td>
                    <td>Immature Dendritic Cells or Transitional States</td>
                    <td>Presence of markers such as PROC, PTCRA, and NRP1 suggests the cluster may represent immature or transitioning pDCs or other dendritic cell precursors.</td>
                </tr>
                
        </tbody>
    </table>
    <details>
        <summary>View Raw LLM Output</summary>
        <pre>Based on the provided marker genes, this cluster is likely associated with plasmacytoid dendritic cells (pDCs) or a closely related subtype. Here's the reasoning and the top 3 most likely detailed subtypes:

1. **Plasmacytoid Dendritic Cells (pDCs)**:
   - **Key markers supporting this subtype**: 
     - **LILRA4**: A canonical marker for pDCs.
     - **CLEC4C** (also known as CD303): Another well-known pDC-specific marker.
     - **IL3RA** (CD123): Highly expressed on pDCs and used to distinguish them from other immune cells.
     - **TPM2, GAS6**: These are associated with pDC function or regulation.
   - pDCs are specialized immune cells found in bone marrow and peripheral blood, known for their role in producing type I interferons in response to viral infections.

2. **Pre-dendritic Cells (Pre-DCs)**:
   - Pre-dendritic cells are progenitors of dendritic cells and share some markers with pDCs, such as **LILRA4** and **CLEC4C**. While they are less differentiated than mature pDCs, their expression profile overlaps significantly, making them a possible subtype.

3. **Immature Dendritic Cells or Transitional States**:
   - Some markers, such as **PROC**, **PTCRA**, and **NRP1**, are associated with cells in transitional or immature states. This could suggest the cluster represents immature or transitioning pDCs or other dendritic cell precursors.

### Additional Notes:
- While the markers strongly suggest pDCs as the primary identity, some markers (e.g., **CUX2**, **SCN9A**, **PHEX**) are less commonly associated with immune cells and may indicate either biological noise, contamination, or novel subtypes of pDCs with unique gene expression profiles.
- Further validation could involve cross-checking with known marker genes for other bone marrow cell types (e.g., myeloid cells, lymphoid cells) and performing pathway or enrichment analysis to confirm the functional identity of the cluster.

Let me know if you'd like to dive deeper into specific genes or pathways!</pre>
    </details>
</div>


    <div class="footer">
        <p>Report generated by CASSIA.</p>
    </div>
</body>
</html>
